GE HealthCare Technologies (GEHC) Gains from Investment Securities (2022 - 2026)

GE HealthCare Technologies has reported Gains from Investment Securities for 5 years, with the latest figure at $92.0 million in Q1 2026.

• For the quarter ending Q1 2026, Gains from Investment Securities rose 1.1% year-over-year to $92.0 million; the trailing twelve-month figure through Mar 2026 stood at $70.0 million (down 87.74% YoY), and the FY2025 full-year result was $69.0 million, down 85.95% from the prior year.
• Gains from Investment Securities for Q1 2026 stood at $92.0 million, up from -$284.0 million in the prior quarter.
• The five-year high for Gains from Investment Securities was $464.0 million in Q4 2023, with the low at -$284.0 million in Q4 2025.
• Historically, Gains from Investment Securities has averaged $62.4 million across 5 years, with a median of $13.0 million in 2023.
• Annual changes were most pronounced in 2023 — Gains from Investment Securities surged 3000.0% — and 2024, when it plunged 1615.38%.
• GE HealthCare Technologies' Gains from Investment Securities stood at -$16.0 million in 2022, then surged by 3000.0% to $464.0 million in 2023, then retreated by 13.58% to $401.0 million in 2024, then slumped by 170.82% to -$284.0 million in 2025, then jumped by 132.39% to $92.0 million in 2026.
• The last three Gains from Investment Securities figures came in at $92.0 million (Q1 2026), -$284.0 million (Q4 2025), and $320.0 million (Q3 2025), per Business Quant data.